Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

FibroGen Revenue 2013-2025 | FGEN

FibroGen revenue from 2013 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
FibroGen Annual Revenue
(Millions of US $)
2024 $30
2023 $47
2022 $141
2021 $235
2020 $176
2019 $257
2018 $213
2017 $131
2016 $183
2015 $181
2014 $138
2013 $102
2012 $66
FibroGen Quarterly Revenue
(Millions of US $)
2025-03-31 $3
2024-12-31 $-93
2024-09-30 $46
2024-06-30 $51
2024-03-31 $25
2023-12-31 $-74
2023-09-30 $40
2023-06-30 $44
2023-03-31 $36
2022-12-31 $34
2022-09-30 $16
2022-06-30 $30
2022-03-31 $61
2021-12-31 $17
2021-09-30 $156
2021-06-30 $24
2021-03-31 $38
2020-12-31 $65
2020-09-30 $44
2020-06-30 $43
2020-03-31 $24
2019-12-31 $8
2019-09-30 $33
2019-06-30 $192
2019-03-31 $24
2018-12-31 $108
2018-09-30 $29
2018-06-30 $44
2018-03-31 $32
2017-12-31 $31
2017-09-30 $41
2017-06-30 $30
2017-03-31 $29
2016-12-31 $36
2016-09-30 $30
2016-06-30 $89
2016-03-31 $28
2015-12-31 $24
2015-09-30 $20
2015-06-30 $121
2015-03-31 $16
2014-12-31 $16
2014-09-30 $14
2014-06-30 $90
2014-03-31 $18
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.030B $0.030B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.321B 31.28
Zoetis (ZTS) United States $67.725B 25.27
Daiichi Sankyo, - (DSNKY) Japan $46.412B 23.79
Takeda Pharmaceutical (TAK) Japan $46.074B 9.16
BeOne Medicines - (ONC) Cayman Islands $31.945B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.145B 0.00
Summit Therapeutics (SMMT) United States $21.292B 0.00
Merck (MKKGY) Germany $17.234B 12.63
Shionogi (SGIOY) Japan $14.649B 14.68
United Therapeutics (UTHR) United States $13.735B 12.15
Neurocrine Biosciences (NBIX) United States $13.077B 44.79
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $10.870B 0.00
Stevanato Group S.p.A (STVN) Italy $8.028B 49.09
Corcept Therapeutics (CORT) United States $7.242B 58.87
Grifols, S.A (GRFS) Spain $6.944B 0.00
Ionis Pharmaceuticals (IONS) United States $6.724B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.625B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.945B 19.38
Crinetics Pharmaceuticals (CRNX) United States $2.902B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.650B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.558B 8.96
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.526B 13.66
Centessa Pharmaceuticals (CNTA) United Kingdom $2.058B 0.00
Ocular Therapeutix (OCUL) United States $1.945B 0.00
Endo (NDOI) United States $1.812B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Harrow (HROW) United States $1.328B 0.00
Guardian Pharmacy Services (GRDN) United States $1.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.206B 24.14
Dyne Therapeutics (DYN) United States $1.131B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.067B 0.00
Enliven Therapeutics (ELVN) United States $1.040B 0.00
Ardelyx (ARDX) United States $1.026B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.992B 0.00
ProKidney (PROK) United States $0.963B 0.00
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Cronos Group (CRON) Canada $0.791B 0.00
Xeris Biopharma Holdings (XERS) United States $0.785B 0.00
KalVista Pharmaceuticals (KALV) United States $0.728B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.727B 0.00
Xencor (XNCR) United States $0.658B 0.00
Relay Therapeutics (RLAY) United States $0.641B 0.00
Organogenesis (ORGO) United States $0.638B 0.00
Zevra Therapeutics (ZVRA) United States $0.614B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.97
Elite Pharmaceuticals (ELTP) United States $0.591B 0.00
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.540B 13.69
Oruka Therapeutics (ORKA) United States $0.534B 0.00
Siga Technologies (SIGA) United States $0.510B 10.66
Tourmaline Bio (TRML) United States $0.508B 0.00
Savara (SVRA) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.412B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.366B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.74
AleAnna (ANNA) United States $0.332B 0.00
Altimmune (ALT) United States $0.331B 0.00
Nanobiotix S.A (NBTX) France $0.321B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.310B 0.00
Esperion Therapeutics (ESPR) United States $0.299B 0.00
Heron Therapeutics (HRTX) United States $0.291B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 24.93
OmniAb (OABI) United States $0.256B 0.00
Larimar Therapeutics (LRMR) United States $0.248B 0.00
Liminatus Pharma (LIMN) United States $0.227B 0.00
MediWound (MDWD) Israel $0.220B 0.00
4D Molecular Therapeutics (FDMT) United States $0.212B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Lyell Immunopharma (LYEL) United States $0.184B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Cassava Sciences (SAVA) United States $0.114B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Nutriband (NTRB) United States $0.095B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Metagenomi (MGX) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.086B 19.50
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Inotiv (NOTV) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Assertio Holdings (ASRT) United States $0.071B 0.00
Wellgistics Health (WGRX) United States $0.068B 0.00
Telomir Pharmaceuticals (TELO) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.061B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
Klotho Neurosciences (KLTO) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 39.06
Prelude Therapeutics (PRLD) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.02
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00